Bharat Biotech received approval from DCGI for emergency use of its vaccine for children aged between 12-18 years, reported ANI citing official sources.
Notably, Zydus Cadila's ZyCoV-D vaccine had earlier received approval for emergency use in children above 12 years.
Meanwhile, the Serum Institute of India's vaccine Covovax, which is being prepared for ages 2 to 18, is also reportedly conducting trials.
